Trials / Recruiting
RecruitingNCT07449195
A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular Tumors
Ocular Imaging for Monitoring of Ocular Tumor Disease
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare two devices used for optical coherence tomography (OCT). OCT is a noninvasive imaging (scanning) method that uses reflected light to create pictures of the back of the eye, and doctors can use OCT to detect and monitor different types of cancer
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Intalight Dream OCT | This is a next-generation swept-source device that has a faster imaging speed and higher sensitivity than the previous generation of frequency-domain OCT devices, which serve as the current standard of care devices. |
| DIAGNOSTIC_TEST | Heidelberg Spectralis OCT | This is the standard of care for optical imaging. |
Timeline
- Start date
- 2026-02-27
- Primary completion
- 2028-02-27
- Completion
- 2028-02-27
- First posted
- 2026-03-04
- Last updated
- 2026-03-04
Locations
7 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT07449195. Inclusion in this directory is not an endorsement.